Incidence of Complications Associated with Parenteral Nutrition in Preterm Infants < 32 Weeks with a Mixed Oil Lipid Emulsion vs a Soybean Oil Lipid Emulsion in a Level IV Neonatal Intensive Care Unit
- 30 August 2020
- journal article
- research article
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 45 (6) , 1204-1212
Abstract
Background: Parenteral nutrition (PN) is crucial for the improvement of long‐term outcomes in very low birth weight (VLBW) neonates. Lipid injectable emulsions are a key component of PN, as they contain essential fatty acids and provide energy critical for brain growth. Prolonged administration increases risk of intestinal failure‐associated liver disease, including cholestasis, and other complications.Methods: This is a retrospective, quasi‐experimental cohort study of 215 VLBW neonates. The primary outcome was a change in direct bilirubin concentration. Secondary outcomes included change in total bilirubin concentration and incidences of cholestasis and other disease states associated with PN and prematurity. Cholestasis was defined as direct bilirubin ≥ 1.0 mg/dL with total bilirubin < 5.0 mg/dL or direct bilirubin > 20% of total bilirubin with total bilirubin > 5.0 mg/dL.Results: Change in direct bilirubin concentration was not different between groups. Incidence of cholestasis was not different between groups per charted diagnosis or per study definition. Non‐stage‐0 retinopathy of prematurity, bronchopulmonary dysplasia, sepsis, and necrotizing enterocolitis were all lower in the mixed oil lipid emulsion group, which remained significant after adjustment for differences in gestational age, birth weight, and PN duration.Conclusions: Although mixed oil lipid emulsion was not found to be associated with a lower risk of cholestasis, it may decrease risks of other disease states associated with PN therapy.Keywords
This publication has 35 references indexed in Scilit:
- Short‐Term Use of Parenteral Nutrition With a Lipid Emulsion Containing a Mixture of Soybean Oil, Olive Oil, Medium‐Chain Triglycerides, and Fish OilJournal of Parenteral and Enteral Nutrition, 2012
- Parenteral nutrition–associated cholestasis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic reviewJournal of Pediatric Surgery, 2012
- Preventing parenteral nutrition liver diseaseEarly Human Development, 2010
- Safety and Efficacy of a Lipid Emulsion Containing a Mixture of Soybean Oil, Medium‐chain Triglycerides, Olive Oil, and Fish Oil: A Randomised, Double‐blind Clinical Trial in Premature Infants Requiring Parenteral NutritionJournal of Pediatric Gastroenterology and Nutrition, 2010
- Intrauterine, Early Neonatal, and Postdischarge Growth and Neurodevelopmental Outcome at 5.4 Years in Extremely Preterm Infants After Intensive Neonatal Nutritional SupportPediatrics, 2009
- Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acidThe Journal of Pediatrics, 2005
- Liver function and plasma antioxidant status in intensive care unit patients requiring total parenteral nutrition: comparison of 2 fat emulsionsJournal of Parenteral and Enteral Nutrition, 2004
- Visual Acuity and the Essentiality of Docosahexaenoic Acid and Arachidonic Acid in the Diet of Term InfantsPediatric Research, 1998
- Prospective controlled study of parenteral nutrition-associated cholestatic jaundice: Effect of protein intakeThe Journal of Pediatrics, 1980
- Total parenteral nutrition in very low birthweight infants: A controlled trialArchives of Disease in Childhood, 1979